Histone deacetylase (HDAC) inhibitors are reported to augment the growth inhibitory effects of 1,25D in a TN breast cancer cell line, MDA-MB-231 by releasing nitric oxide (NO) [21]. The gene discussed is HDAC9; the disease is breast carcinoma.